Ben O'Leary

7PUBLICATIONS
44CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsImmunogenetics (incl. genetic immunology)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 14, 2026
Salvage Neck Dissection in Recurrent Head and Neck Squamous Cell Carcinoma After Primary Radiotherapy (RESCUE): An IReC Multicentre Consecutive Cohort Study.

|Mar 04, 2026
Homologous recombination deficiency and hemizygosity drive resistance in breast cancer.

Anton Safonov, Minna Lee, David N Brown

|Aug 06, 2025
Tumor Evolution Driving Genome Instability, Immune Interactions, and Response to Radiotherapy.

George Seed, France Truong, Rahma Riahi

|May 13, 2022
Overall Survival with Palbociclib and Fulvestrant in Women with HR+/HER2- ABC: Updated Exploratory Analyses of PALOMA-3, a Double-blind, Phase III Randomized Study.

Massimo Cristofanilli, Hope S Rugo, Seock-Ah Im

|Mar 03, 2018
Early circulating tumor DNA dynamics and clonal selection with palbociclib and fulvestrant for breast cancer.

Ben O'Leary, Sarah Hrebien, James P Morden

Pageof 2

Frequent Collaborators

1 joint publications

Massimo Cristofanilli

1 joint publications

Seock-Ah Im

1 joint publications

Nadia Harbeck

1 joint publications

Igor Bondarenko